US drug pricing and FDA approval history

Price and approval history for every US drug product, linked at NDC level so it joins cleanly with claims and formulary data.

What's included

• Wholesale acquisition cost (WAC) per unit with effective dates and percentage change for each price move
• National Average Drug Acquisition Cost (NADAC) per unit, weekly
• FDA approval type and date, application number and Orange Book therapeutic equivalence codes
• Product attributes: active ingredient, strength, dosage form, route, package size and manufacturer
• Launch, discontinuation and generic-entry events

How buyers use it

• Tracking list price increases by manufacturer and therapeutic class
• Forecasting generic and biosimilar erosion after loss of exclusivity
• Benchmarking acquisition costs in pharmacy and payer analytics
• Supporting market-access and pricing strategy for new launches

Coverage and methodology

List price changes are compiled from manufacturer price notices and state drug price transparency filings, and checked against prior values; any change above 10% is reviewed by an analyst. NADAC comes from the weekly CMS files. Approvals and equivalence codes come from Drugs@FDA and the Orange Book. Everything is linked at 11-digit NDC level and rolled up to product and ingredient. Prices are list and survey-based acquisition costs, not net prices after rebates. History runs from 2013 and updates weekly.